Primary bladder pain syndrome
Conditions
Interventions
Experimental group:PRP two-stage intravesical injection (first once a week three times a week, then once a month three times a month) with 15 ml each time. (PRP extraction method is chosen by the pati
Sponsors
The First Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. 18 years old< = age< = 80 years old; 2. Typical glomerular hemorrhage-like changes after cystoscopic water dilatation; 3. Preoperative examination to rule out other diseases such as tumors; 4. Have received at least 2 or more traditional treatment methods recommended by guidelines including oral drugs and bladder perfusion in the past, but the symptoms have not improved or recurred; 5. All patients voluntarily participated in this study and signed the relevant informed consent form.
Exclusion criteria
Exclusion criteria: 1. Hemoglobin (Hb) < 120 g/L, platelet (Plt) < 120×10^9/L; 2. Recurrent urinary tract infections or recent acute urinary tract infections; 3. Severe liver and kidney dysfunction or cardiac insufficiency who cannot tolerate intravenous general anesthesia; 4. Women who plan to become pregnant, pregnant or lactating; 5. Patients with ulcerative symptoms of cystoscopy; 6. Other situations that the investigator considers unsuitable for participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General reaction assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Urinary diary;O'leary-sant score;Pain visual analogue scale score,VAS;Pelvic pain and urgency,frequency score,PUF; | — |
Countries
China
Contacts
Public ContactWang Qingwei
The First Affiliated Hospital of Zhengzhou University
Outcome results
None listed